Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice
Luca Bravi, Noemi Rudini, Roberto Cuttano, Costanza Giampietro, Luigi Maddaluno, Luca Ferrarini, Ralf H Adams, Monica Corada, Gwenola Boulday, Elizabeth Tournier-Lasserve, Elisabetta Dejana, Maria Grazia Lampugnani, Luca Bravi, Noemi Rudini, Roberto Cuttano, Costanza Giampietro, Luigi Maddaluno, Luca Ferrarini, Ralf H Adams, Monica Corada, Gwenola Boulday, Elizabeth Tournier-Lasserve, Elisabetta Dejana, Maria Grazia Lampugnani
Abstract
Cerebral cavernous malformation (CCM) is a disease of the central nervous system causing hemorrhage-prone multiple lumen vascular malformations and very severe neurological consequences. At present, the only recommended treatment of CCM is surgical. Because surgery is often not applicable, pharmacological treatment would be highly desirable. We describe here a murine model of the disease that develops after endothelial-cell-selective ablation of the CCM3 gene. We report an early, cell-autonomous, Wnt-receptor-independent stimulation of β-catenin transcription activity in CCM3-deficient endothelial cells both in vitro and in vivo and a triggering of a β-catenin-driven transcription program that leads to endothelial-to-mesenchymal transition. TGF-β/BMP signaling is then required for the progression of the disease. We also found that the anti-inflammatory drugs sulindac sulfide and sulindac sulfone, which attenuate β-catenin transcription activity, reduce vascular malformations in endothelial CCM3-deficient mice. This study opens previously unidentified perspectives for an effective pharmacological therapy of intracranial vascular cavernomas.
Keywords: cerebral cavernous malformation; endothelial cells; sulindac metabolites; vascular pathology; β-catenin.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Source: PubMed
Próximos ensaios clínicos
-
NCT07951489RecrutamentoTraumatismo Cranioencefálico TCE
-
NCT07951333Ainda não está recrutandoTromboembolismo venoso | Cirurgia pélvica | Cirurgia de Câncer Abdominal
-
NCT07951658Recrutamento
-
NCT07951281Ainda não está recrutandoDoença Pulmonar Obstrutiva Crônica | Hipercapnia
-
NCT07889349Recrutamento
-
NCT07951099Ainda não está recrutandoCâncer de próstata
-
NCT07951320Ainda não está recrutando
-
NCT07950293Ainda não está recrutandoQualidade do Sono | Intervenção dietética | Estresse percebido | Confusão mental
-
NCT07951034Ainda não está recrutandoCâncer de Mama Metastático | Câncer de Mama Positivo para Receptores Hormonais | Câncer de Mama HER2-baixo
-
NCT07950111Ainda não está recrutando
-
NCT07950566Ainda não está recrutandoHemiparesia | Espasticidade | Espasticidade dos Membros Superiores
-
NCT07950072Recrutamento